about
Integrated biophysical approach to fragment screening and validation for fragment-based lead discoveryLarge scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologiesTarget immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics.Fragment-based approaches to enzyme inhibitionAlzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).Evolutions in fragment-based drug design: the deconstruction-reconstruction approachSmall-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.A decade of fragment-based drug design: strategic advances and lessons learned.Computational medicinal chemistry in fragment-based drug discovery: what, how and when.Fragment-based drug discovery using the SHAPES method.Fragment-based screening by biochemical assays: Systematic feasibility studies with trypsin and MMP12.High-Throughput Chemical Probing of Full-Length Protein-Protein Interactions.
P2860
Q27679154-95A0509D-5065-4436-9055-F1532B6CF2E0Q27697268-F5E757D5-A08B-4E17-8D5F-3F0A4ABCF8E9Q33684605-0FD0B61A-884F-49B0-8B31-D6C729B6245FQ33908733-077BA7A1-4F01-41FD-8BD5-57BE5D06B945Q34706518-1BC596AD-EDDA-40C3-BF81-C0571371005DQ34767547-9E5FF4A0-F475-4022-99D9-BB221F7AA169Q35009555-37AF5560-3395-4265-81DF-F790C05ECBABQ35092268-49534F2B-167C-4B69-85C4-5D281FC77737Q35122653-4AAB98A9-E34F-43A0-8693-3A0C45F78A41Q36732253-787E4704-3537-4FBF-94DB-E744665C55D9Q37856296-0163FCCD-6932-47E1-8047-1A5ABC909B6BQ38089130-331E9D68-FFAF-4D80-82F8-8424BF71D4C8Q42882505-BFBB550A-A131-4E85-8529-2BA93A8F01CCQ47431069-F5F8D667-A153-401F-BE46-90C196DA880B
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Fragment screening by biochemical assay.
@en
Fragment screening by biochemical assay.
@nl
type
label
Fragment screening by biochemical assay.
@en
Fragment screening by biochemical assay.
@nl
prefLabel
Fragment screening by biochemical assay.
@en
Fragment screening by biochemical assay.
@nl
P2093
P2860
P356
P1476
Fragment screening by biochemical assay.
@en
P2093
Dirk Ullmann
John Barker
Mark Whittaker
Steve Courtney
Thomas Hesterkamp
P2860
P304
P356
10.1517/17460441.1.3.225
P407
P577
2006-08-01T00:00:00Z